Latest News

APRIL 17, 2019 New Venturetec's Major Investment, Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plc MORE
APRIL 15, 2019 Conversion of Convertible Note CHF 12 Mio. held by Friedli Corporate Finance GmbH, Zug MORE
APRIL 03, 2019 New Venturetec Ltd. revenue expectation for the first half of the fiscal year 2018/2019 ended March 31, 2019 MORE
DECEMBER 03, 2018 Voting of the shareholders at the annual shareholders meeting 2018 MORE

Stock Info

Stock Price, April 15, 2019: CHF 9.05
Net Asset Value, April 15, 2019: CHF 11.85
Performance year to date: +67.31%